AQR Capital Management’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.64M Buy
514,789
+208,582
+68% +$3.29M ﹤0.01% 1803
2025
Q4
$5.59M Buy
306,207
+31,048
+11% +$523K ﹤0.01% 1515
2025
Q3
$4.03M Sell
275,159
-184,722
-40% -$3.17M ﹤0.01% 1579
2025
Q2
$8.37M Sell
459,881
-60,007
-12% -$1.22M 0.01% 1043
2025
Q1
$10.3M Sell
519,888
-10,280
-2% -$178K 0.01% 863
2024
Q4
$9.09M Sell
530,168
-59,145
-10% -$1.11M 0.01% 853
2024
Q3
$11.8M Sell
589,313
-184,093
-24% -$2.86M 0.02% 759
2024
Q2
$8.65M Sell
773,406
-43,547
-5% -$365K 0.01% 805
2024
Q1
$5.39M Buy
816,953
+225,750
+38% +$1.23M 0.01% 953
2023
Q4
$2.67M Buy
591,203
+49,160
+9% +$182K 0.01% 1220
2023
Q3
$1.94M Buy
542,043
+90,236
+20% +$347K ﹤0.01% 1338
2023
Q2
$1.67M Buy
451,807
+312,493
+224% +$1.16M ﹤0.01% 1339
2023
Q1
$461K Buy
139,314
+16,463
+13% +$56.9K ﹤0.01% 1807
2022
Q4
$477K Buy
122,851
+48,655
+66% +$150K ﹤0.01% 1834
2022
Q3
$180K Buy
+74,196
New +$178K ﹤0.01% 2055
2020
Q3
Sell
-29,215
Closed -$86K 2171
2020
Q2
$86K Buy
+29,215
New +$83.9K ﹤0.01% 2066

Other funds holding ADMA